Table 1 Anthropometric and metabolic characteristics of study participants. Data are presented as mean ± standard deviation. P-value for differences between time points before and after VLCD was determined using paired Student’s test.
before VLCD (n = 20) | after VLCD (n = 20) | 14d after VLCD (n = 20) | p - value | |
|---|---|---|---|---|
t1 | t2 | t3 | t1−t2 | |
Weight (kg) | 95.1 ± 13.4 | 88.2 ± 12.3 | 88.5 ± 12.6 | <0.001 |
BMI (kg/m²) | 34.9 ± 3.8 | 32.5 ± 3.5 | 32.6 ± 3.8 | <0.001 |
Waist circumference (cm) | 106.9 ± 10.6 | 101.2 ± 9.4 | 100.5 ± 9.3 | <0.001 |
Hip circumference (cm) | 118.5 ± 12.6 | 113.9 ± 10.8 | 114.4 ± 11.5 | <0.001 |
Lean mass (kg) | 52.7 ± 5.7 | 50.0 ± 5.5 | 50.9 ± 5.3 | <0.001 |
Fat mass (kg) | 42.5 ± 8.8 | 38.2 ± 7.9 | 37.6 ± 8.4 | <0.001 |
RMR (kJ/day) | 7,016 ± 109 | 6,689 ± 707 | 7,061 ± 716 | 0.07 |
Total cholesterol (mmol/L) | 4.9 ± 1.0 | 4.2 ± 0.8 | 4.8 ± 0.9 | <0.001 |
HDL-c (mmol/L) | 1.3 ± 0.2 | 1.1 ± 0.2 | 1.3 ± 0.3 | <0.001 |
LDL-c (mmol/L) | 3.1 ± 0.9 | 2.6 ± 0.7 | 2.9 ± 0.8 | <0.001 |
Triglycerides (mmol/L) | 1.4 ± 0.7 | 1.1 ± 0.5 | 1.3 ± 0.7 | 0.05 |
LDL/HDL | 2.4 ± 0.8 | 2.3 ± 0.7 | 2.2 ± 0.7 | 0.68 |
NEFA (mmol/L) | 0.6 ± 0.2 | 0.7 ± 0.2 | 0.5 ± 0.2 | 0.03 |
Fasting glucose (mmol/L) | 4.8 ± 0.7 | 4.5 ± 0.6 | 4.7 ± 0.6 | <0.001 |
Glucose 120 minutes (mmol/L) | 6.5 ± 2.4 | 6.8 ± 1.3 | not assessed | 0.16 |
Fasting insulin (pmol/L) | 63.7 ± 44.6 | 44.3 ± 20.6 | 59.7 ± 62.9 | <0.001 |
HOMA-IR | 2.05 ± 1.52 | 1.29 ± 0.68 | 1.77 ± 1.82 | <0.001 |
hsCRP (µg/L) | 3.1 ± 3.7 | 1.7 ± 1.6 | 2.7 ± 2.6 | <0.01 |
HMW Adiponectin (µg/L) | 4.1 ± 2.2 | 4.7 ± 2.7 | 4.9 ± 2.8 | <0.01 |
Leptin (µg/L) | 43.8 ± 25.2 | 20.9 ± 16.1 | 25.9 ± 20.3 | <0.001 |
RANTES (µg/L) | 47.6 ± 19.3 | 45.6 ± 22.6 | 39.8 ± 24.1 | 0.28 |
MCP-1 (ng/L) | 82.1 ± 32.6 | 84.5 ± 23.4 | 89.1 ± 25.5 | 0.5 |
Chemerin (µg/L) | 77.6 ± 25.7 | 64.8 ± 20.2 | 75.7 ± 21.1 | <0.01 |
LBP (µg/L) | 27.3 ± 3.3 | 25.8 ± 3.5 | 28.0 ± 3.5 | <0.01 |
Calprotectin (µg/L) | 424.9 ± 560.3 | 342.9 ± 351.6 | 142.9 ± 132.9 | 0.85 |